|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
||||||||||||||||||||||||||||||||||
|
|||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Human Serine threonine-protein phosphatase 6 catalytic (aa 1-305) |
| PPP6 Swiss Prot# | | O00743 |
| PPP6 Protein names | | Serine/threonine-protein phosphatase 6 catalytic subunit (PP6C) (EC 3.1.3.16) |
| PPP6 Gene names | | PPP6C (PPP6) |
| Organism | | Human |
| PPP6 Entry name | | PPP6_HUMAN |
| PPP6 Codon optimized cDNA(gene) Clone |
| PPP6 Cat # | | RPT0158 |
| Tag | | PPP6 contains A 6x histidine tag |
| PPP6 Formulation | | Liquid |
| PPP6 Storage | | Storage at -20℃ to −80℃ Upon receipt. Avoid repeated freeze-thaw cycles. |
| PPP6 Applications | | Applications: 1. Codon-optimized cDNA(gene) sequence designed for protein production in both E.coli and Mammalian cell. The cDNA(gene) has been cloned into E.coli expression vector with 6x Histidine tag.2. May be used as RNAi assistance to restore the loss-of-function. |
| Recombinant PPP6 Protein |
| PPP6 Cat # | | PT0158 |
| PPP6 Source | | recombinant |
| PPP6 Applications | | Western Blot, SDS-Page or may be used for other applications determined by user |
| PPP6 Purity | | >90%, as determined by SDS-PAGE under reducing conditions |
| PPP6 Activity | | N/A |
| Tag | | PPP6 Contains A 6x histidine tag |
| PPP6 Formulation | | Liquid |
| PPP6 Storage | | ;. Storage at -20℃ to −80℃ Upon receipt. Avoid repeated freeze-thaw cycles. |
| Place Order for Recombinant PPP6 Products | | For pricing and availability Click Here >>> |
| PPP6 family | | PPP phosphatase family, PP-6 (PP-V) subfamily |
| PPP6 Subcellular locations | | Cytoplasm. |
| PPP6 FUNCTION According to UniProtKB Swiss Prot | | FUNCTION: Catalytic subunit of protein phospatase 6 (PP6). PP6 is a component of a signaling pathway regulating cell cycle progression in response to IL2 receptor stimulation. N-terminal domain restricts G1 to S phase progression in cancer cells, in part through control of cyclin D1. Downregulates MAP3K7 kinase activation of the IL1 signaling pathway by dephosphorylation of MAP3K7. |
| PPP6 Sequence | | DDBJ | EMBL | GenBank |
| PPP6 3D structure | | ModBase |
| PPP6 interaction | | STRING |
| PPP6 Proteomic | | PRIDE |
| PPP6 Proteomic | | Ensembl | GeneID | KEGG | UCSC |
| PPP6 Organism specific | | CTD | MGI |
| PPP6 Phylogenomics | | eggNOG | GeneTree | HOGENOM | HOVERGEN |
| | InParanoid | OrthoDB | PhylomeDB | OMA |
| PPP6 Gene expression | | Bgee | ArrayExpress | Genevestigator |
| PPP6 Family and domain | | InterPro | PROSITE | ProtoNet |
| FOR in vitro RESEARCH USE ONLY |